← Back to Search

DSM-H for Dementia

N/A
Waitlist Available
Led By Abraham Brody, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to day 60
Awards & highlights

Study Summary

This trial will study whether a quality improvement program can help improve the quality of life and reduce healthcare utilization for persons with dementia and their caregivers.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to day 60
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 60 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Caregiver-Targeted Quality of Life Measure Score - ADL Scale
Change in Caregiver-Targeted Quality of Life Measure Score - Benefits of Caregiving Scale
Change in Caregiver-Targeted Quality of Life Measure Score - Caregiver Feelings Scale
+10 more
Secondary outcome measures
Personality inventories
Advance Directives
Change in Public Health Questionnaire-9 (PHQ-9) Score Among Caregivers
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: QI program careExperimental Treatment1 Intervention
DSM-H performance improvement program Patients in the performance improvement group will receive care from a care team who has received the DSM-H performance improvement program
Group II: ControlActive Control1 Intervention
Receive usual care from a care team who has not received the performance improvement program
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DSM-H
2018
N/A
~220

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,370 Previous Clinical Trials
840,587 Total Patients Enrolled
17 Trials studying Dementia
67,736 Patients Enrolled for Dementia
Abraham Brody, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Dementia Symptom Management at Home Program
2018. "Dementia Symptom Management at Home Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03255967.
~33 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top